期刊文献+

中药干预提高进展期胃癌生存期及生存质量的临床研究 被引量:5

Clinical research on intervention of traditional Chinese medicine in improving the survival time and life quality for advanced gastric cancer
下载PDF
导出
摘要 目的观察中药干预对进展期胃癌患者生存期和生活质量的影响。方法采用平行随机双盲的方法,将200例患者分为2组,对照组采用XELOX方案化疗,观察组采用中药联合XELOX方案治疗。观察2组患者疗效、生存期和生活质量。结果观察组不良反应发生率显著低于对照组(P<0.05)。2组生活质量评分比较有显著性差异(P<0.05)。观察组1 a、2 a生存率显著高于对照组。观察组近期缓解率略高于对照组,但无显著性差异(P>0.05)。结论加用中药干预可明显改善进展期胃癌患者的生活质量,延长其生存期。 Objective It is to observe the influence of intervention of traditional Chinese medicine (TCM) on the survival time and life quality of patients with advanced gastric cancer ( AGC ). Methods 200 patients were randomly divided into observed group and control group with the way of randomized and parallel-control. The patients were treated with chemotherapeutic schedule of XELOX simply in control group and with TCM plus XELOX in observed group. The clinical effect, survival time and life quality were observed in both groups. Results The rate of adverse reaction in observe group was markedly lower than that in control group (P 〈 0.05). There was significant difference in life quality between two groups ( P 〈 0.05 ). The survival rate of 1 - or2 - year in observe group was markedly higher than that in control group ( all P 〈 0.05 ). There was no significant difference in recent remission rate between both groups ( P 〉 0.05 ). Conclusion TCM intervention can obviously improve the life quality of patients with AGC, and extend their survival time.
出处 《现代中西医结合杂志》 CAS 2013年第33期3649-3650,3653,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 陕西省中医药管理局课题(1c63)
关键词 中医药 进展期胃癌 生存期 生活质量 traditional Chinese medicine advanced gastric cancer survival time life quality
  • 相关文献

参考文献12

  • 1Howe HL,Wu X, Ries LA ,et a|. Annual report to the nation on the status afcancer, 1975 - 2003 , featuringcancer among U. S. Hispanic/Latino populations [ J ]. Canc- er,2006,107(8) :1711 -1742.
  • 2Kamangar F, Dores GM, Arderson WF. Patterns of cancer inci- dence, mortality, and Prevalence across five continents : defining pri- orities to reduce cancer disparities in different geographic regions of the worldI J]. J Clin Oncol,2006 ,24 :2137 - 2150.
  • 3Cunningham D,Allum WH,Stenning SP,et al. Perioperative chem- otherapy versus alone for resectable gastroesophageal cancer[ J]. N Engl J Med,2006,355 : 11 - 20.
  • 4Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocareinoma resection : eighteen-year experience at a single insti- tution [ J ]. Gastrointest Surg,2005,9 ( 5 ) :718 - 725.
  • 5Katsuhiko H,Alexandria P,Jaffer A. Gastric cancer:advances in ad- juvant and adjunct therapy [ J ]. Curr Treat Opt Oncol,2003,4 (5) : 413 -419.
  • 6金懋林.进展期胃癌全身化学治疗新进展[J].外科理论与实践,2003,8(1):18-20. 被引量:11
  • 7孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.
  • 8孟琼,罗家洪,万崇华,许传志,李高峰,寸英丽.胃癌患者生命质量测定量表EORTC QLQ-STO22中文版的制定和评价[J].昆明医科大学学报,2012,33(10):34-38. 被引量:24
  • 9He J,Gu D,Wu X,et al. Major causes of death among men and women in China[J]. N EngJ Med,2005,353(ll):1124-1134.
  • 10Oeffinger KC, Hudson MM. Long-term complications following child- hood and adolescent cancer: foundations for providing risk-based health care for survivors[J]. CA Cancer J C1in,2004,54(4) :208 -236.

二级参考文献63

共引文献376

同被引文献88

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部